These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


355 related items for PubMed ID: 19061196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy.
    Poppelreuter M, Weis J, Bartsch HH.
    J Psychosoc Oncol; 2009; 27(2):274-96. PubMed ID: 19337933
    [Abstract] [Full Text] [Related]

  • 4. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
    Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S.
    Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746
    [Abstract] [Full Text] [Related]

  • 5. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA.
    Cancer; 2004 Jun 01; 100(11):2292-9. PubMed ID: 15160331
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.
    Psychooncology; 2009 Aug 01; 18(8):811-21. PubMed ID: 19085975
    [Abstract] [Full Text] [Related]

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 01; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 9. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy.
    Mehlsen M, Pedersen AD, Jensen AB, Zachariae R.
    Psychooncology; 2009 Mar 01; 18(3):248-57. PubMed ID: 18756583
    [Abstract] [Full Text] [Related]

  • 10. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
    Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.
    Psychooncology; 2009 Feb 01; 18(2):134-43. PubMed ID: 18551510
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy.
    Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, van Dam FS.
    Breast Cancer Res Treat; 2005 Nov 01; 94(1):53-61. PubMed ID: 16175317
    [Abstract] [Full Text] [Related]

  • 12. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF.
    J Clin Oncol; 2005 Nov 01; 23(31):8025-32. PubMed ID: 16258100
    [Abstract] [Full Text] [Related]

  • 13. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA.
    Cancer; 2004 Aug 01; 101(3):466-75. PubMed ID: 15274059
    [Abstract] [Full Text] [Related]

  • 14. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
    Hermelink K, Küchenhoff H, Untch M, Bauerfeind I, Lux MP, Bühner M, Manitz J, Fensterer V, Münzel K.
    Psychooncology; 2010 Dec 01; 19(12):1321-8. PubMed ID: 20127909
    [Abstract] [Full Text] [Related]

  • 15. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.
    Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, Muller MJ, van Dam FS.
    Clin Breast Cancer; 2006 Apr 01; 7(1):67-78. PubMed ID: 16764746
    [Abstract] [Full Text] [Related]

  • 16. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D.
    Breast; 2005 Apr 01; 14(2):142-50. PubMed ID: 15767184
    [Abstract] [Full Text] [Related]

  • 17. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF.
    J Clin Oncol; 2003 Nov 15; 21(22):4175-83. PubMed ID: 14615445
    [Abstract] [Full Text] [Related]

  • 18. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB, van Dam FS.
    J Clin Oncol; 2006 Nov 10; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract] [Full Text] [Related]

  • 19. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K.
    Cancer; 2008 Nov 01; 113(9):2431-9. PubMed ID: 18823033
    [Abstract] [Full Text] [Related]

  • 20. Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation.
    Poppelreuter M, Weis J, Mumm A, Orth HB, Bartsch HH.
    Bone Marrow Transplant; 2008 Jan 01; 41(1):79-90. PubMed ID: 17934527
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.